Saragossa, Spain

Maria Pilar Zaragoza Fernández

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Pilar Zaragoza Fernández: Innovator in Therapeutic Applications

Introduction

Maria Pilar Zaragoza Fernández is a notable inventor based in Saragossa, Spain. She has made significant contributions to the field of medical research, particularly in the therapeutic use of toxins for treating neurological conditions. Her work has the potential to impact the lives of many individuals suffering from serious diseases.

Latest Patents

Maria Pilar Zaragoza Fernández holds a patent for the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin. This invention relates to the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. The innovative approach she has developed could offer new hope for patients affected by this condition.

Career Highlights

Throughout her career, Maria Pilar has been associated with prestigious institutions such as the University of Zaragoza and the Autonomous University of Barcelona. Her academic and research endeavors have positioned her as a leading figure in her field, contributing to advancements in therapeutic applications.

Collaborations

Maria Pilar has collaborated with esteemed colleagues, including María Moreno Igoa and Ana Cristina Calvo Royo. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Maria Pilar Zaragoza Fernández exemplifies the spirit of innovation in the medical field. Her work on the therapeutic use of the tetanus toxin highlights her commitment to improving patient outcomes. Through her research and collaborations, she continues to pave the way for future advancements in treatment options for ALS and other neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…